Loratadine Market Size

Loratadine Market size was valued at USD 140.1 million in 2023 and is anticipated to grow at a CAGR of 2.8% between 2024 – 2032. One of the major growth drivers is the increasing prevalence of allergic rhinitis and other allergic disorders globally.

For instance, as per a study published in 2022, allergic rhinitis (AR) represents a global health concern where it affects approximately 400 million people worldwide. Loratadine, known for its effectiveness in relieving symptoms such as sneezing, itching, and runny nose, is widely prescribed to manage these conditions, thereby fueling market growth. Additionally, the growing awareness among patients regarding the OTC availability and benefits of allergic rhinitis drugs, such as loratadine is contributing to its market expansion. Moreover, the availability of loratadine in various forms such as tablets, syrups, and dissolvable tablets, providing convenience to patients of different age groups, further propels market growth.

Loratadine is a second-generation antihistamine drug commonly used to treat allergic rhinitis (hay fever), as well as symptoms of urticaria (hives) such as itching, redness, and swelling. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. Loratadine is available in various forms, including tablets, syrup, and capsules. It is often preferred for its non-drowsy formulation, making it suitable for daytime use.